• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal

The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next
  • expand AZD3355 Dose-escalation Study in Healthy Males
    Study Id
    D9120C00030
    Disease
    gastroesophageal reflux disease
    Drug Name
    AZD3355
    Study Name
    D9120C00030
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Apr 2, 2009
    • D9120C00030.pdf (505 KB)
  • expand TLESR-impedance Study in Patients
    Study Id
    D9120C00020
    Disease
    gastroesophageal reflux disease
    Drug Name
    AZD3355
    Study Name
    D9120C00020
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Dec 2, 2008
    • D9120C00020.pdf (524 KB)
  • expand Drug Interaction Study Between AZD3355 and Nexium
    Study Id
    D9120C00016
    Disease
    gastroesophageal reflux disease
    Drug Name
    AZD3355
    Study Name
    D9120C00016
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Dec 4, 2008
    • D9120C00016.pdf (529 KB)
  • expand Symptom Improvements in GERD Patients
    Study Id
    D9120C00011
    Disease
    gastroesophageal reflux disease
    Drug Name
    AZD3355
    Study Name
    D9120C00011
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Oct 24, 2007
    • D9120C00011.pdf (160 KB)
  • expand Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (C27)
    Study Id
    D9120C00027
    Disease
    gastroesophageal reflux disease
    Drug Name
    AZD3355
    Study Name
    D9120C00027
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Jun 23, 2009
    • D9120C00027.pdf (143 KB)
  • expand Renal Impairment Study
    Study Id
    D9120C00022
    Disease
    gastroesophageal reflux disease
    Drug Name
    AZD3355
    Study Name
    D9120C00022
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Jul 20, 2010
    • D9120C00022.pdf (608 KB)
  • expand A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study.
    Study Id
    NIS-GBG-NEX-2009/1
    Disease
    acid reflux
    Drug Name
    Nexium
    Study Name
    NIS-GBG-NEX-2009/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Jan 7, 2011
    • NIS-GBG-NEX-2009_1.pdf (202 KB)
  • expand Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
    Study Id
    NIS-GEU-DUM-2008/1
    Disease
    acid reflux
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GEU-DUM-2008/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Dec 2, 2010
    • NIS-GEU-DUM-2008_1.pdf (374 KB)
  • expand Omeprazole and Ranitidine in the Treatment of Patients with Erosive Esophagitis Not Responding to Treatment withH2-Receptor Antagonists: A Double-Blind, Controlled, Multicentre study.
    Study Id
    I-613
    Disease
    acid reflux
    Drug Name
    Losec
    Study Name
    I-613
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Jan 18, 1971
    • I-613.pdf (85 KB)
  • expand Omeprazole in the Long-Term Management of Duodenal Ulcers – A comparative study of omeprazole and ranitidine in high risk duodenal ulcer disease.
    Study Id
    I-598
    Disease
    acid reflux
    Drug Name
    Losec
    Study Name
    I-598
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report
    Jan 18, 1971
    • I-598.pdf (70 KB)
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013